Back to DE D. E. Shaw & Co., Inc.

AMRXAMRX
26 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in AMNEAL PHARMACEUTICALS INC

D. E. Shaw & Co., Inc. holds 1.7M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $21.4M as of 2026-Q1. The position was decreased (-35.4% shares). AMRX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$21.4M

Current Shares

1.7M

Total Value Change

+$10.5M

Total Shares Change

+917,092

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.7M
-35.4%
$21.4M0.0%$13.31
0
2025-Q4
Increased
2.7M
+70.1%
$33.5M0.0%$12.88
43
2025-Q3
Increased
1.6M
+69.5%
$15.7M0.0%$9.87
42
2025-Q2
Increased
923,644
+5732.6%
$7.5M0.0%$8.13
44
2025-Q1
New
15,836
-
$132,7060.0%$8.28
31
2024-Q3
Exited
0
-100.0%
$00.0%$8.19
0
2024-Q2
Decreased
89,895
-60.3%
$570,8330.0%$6.35
0
2024-Q1
Decreased
226,204
-66.0%
$1.4M0.0%$6.06
0
2023-Q4
Decreased
666,036
-23.9%
$4M0.0%$6.07
0
2023-Q3
Increased
874,916
+40.6%
$3.7M0.0%$4.22
35
2023-Q2
Decreased
622,226
-1.3%
$1.9M0.0%$2.87
0
2023-Q1
Decreased
630,109
-8.5%
$875,8520.0%$1.36
0
2022-Q4
Increased
688,837
+164.1%
$1.4M0.0%$1.99
41
2022-Q3
Increased
260,850
+38.1%
$527,0000.0%$2.09
32
2022-Q2
Decreased
188,927
-25.6%
$601,0000.0%$3.32
0
2022-Q1
Increased
253,999
+60.7%
$1.1M0.0%$4.22
36
2021-Q4
Increased
158,022
+775.9%
$757,0000.0%$4.86
40
2021-Q3
New
18,042
-
$96,0000.0%$5.50
30
2021-Q2
Exited
0
-100.0%
$00.0%$5.15
0
2021-Q1
New
122,774
-
$826,0000.0%$6.66
34
2020-Q1
Exited
0
-100.0%
$00.0%$3.07
0
2019-Q4
Increased
224,285
+126.1%
$1.1M0.0%$4.50
41
2019-Q3
Decreased
99,204
-37.5%
$288,0000.0%$3.20
0
2019-Q2
Decreased
158,679
-62.6%
$1.1M0.0%$7.17
0
2019-Q1
Decreased
423,980
-47.2%
$6M0.0%$14.17
0
2018-Q4
New
802,862
-
$10.9M0.0%$13.85
38

Other major holders of AMRX: BlackRock, Inc., VANGUARD GROUP INC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used